These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 25369612

  • 1. Sensitivity of individual donor nucleic acid testing (NAT) for the detection of hepatitis B infection by studying diluted NAT yield samples.
    Arora S, Doda V, Kirtania T.
    Blood Transfus; 2015 Apr; 13(2):227-32. PubMed ID: 25369612
    [Abstract] [Full Text] [Related]

  • 2. Blood donor screening in the Netherlands: Universal anti-HBc screening in combination with HBV nucleic acid amplification testing may allow discontinuation of hepatitis B virus antigen testing.
    van de Laar TJ, Hogema BM, Molenaar-de Backer MW, Marijt-van der Kreek T, Zaaijer HL.
    Transfusion; 2021 Jul; 61(7):2116-2124. PubMed ID: 33899233
    [Abstract] [Full Text] [Related]

  • 3. Hepatitis B virus nucleic acid amplification testing of Australian blood donors highlights the complexity of confirming occult hepatitis B virus infection.
    Kiely P, Margaritis AR, Seed CR, Yang H, Australian Red Cross Blood Service NAT Study Group.
    Transfusion; 2014 Aug; 54(8):2084-91. PubMed ID: 24650170
    [Abstract] [Full Text] [Related]

  • 4. Serological characterization of occult hepatitis B virus infection among blood donors in India.
    Doda V, Arora S, Kirtania T.
    Transfus Apher Sci; 2014 Oct; 51(2):162-7. PubMed ID: 25131822
    [Abstract] [Full Text] [Related]

  • 5. Blood donor testing for hepatitis B virus in the United States: is there a case for continuation of hepatitis B surface antigen detection?
    Dodd RY, Nguyen ML, Krysztof DE, Notari EP, Stramer SL.
    Transfusion; 2018 Sep; 58(9):2166-2170. PubMed ID: 30144082
    [Abstract] [Full Text] [Related]

  • 6. Detection of different categories of hepatitis B virus (HBV) infection in a multi-regional study comparing the clinical sensitivity of hepatitis B surface antigen and HBV-DNA testing.
    Lelie N, Bruhn R, Busch M, Vermeulen M, Tsoi WC, Kleinman S, International NAT Study Group.
    Transfusion; 2017 Jan; 57(1):24-35. PubMed ID: 27673757
    [Abstract] [Full Text] [Related]

  • 7. Sensitivity of hepatitis B virus DNA transcription-mediated amplification testing in hepatitis B surface antigen-positive blood donations.
    Bouchardeau F, Girault A, Razer A, Servant-Delmas A, Mercier M, Laperche S.
    Transfusion; 2006 Dec; 46(12):2047-52. PubMed ID: 17176315
    [Abstract] [Full Text] [Related]

  • 8. Blood donation screening for hepatitis B virus markers in the era of nucleic acid testing: are all tests of value?
    Stramer SL, Zou S, Notari EP, Foster GA, Krysztof DE, Musavi F, Dodd RY.
    Transfusion; 2012 Feb; 52(2):440-6. PubMed ID: 21810101
    [Abstract] [Full Text] [Related]

  • 9. New strategies for blood donor screening for hepatitis B virus: nucleic acid testing versus immunoassay methods.
    Kuhns MC, Busch MP.
    Mol Diagn Ther; 2006 Feb; 10(2):77-91. PubMed ID: 16669606
    [Abstract] [Full Text] [Related]

  • 10. Molecular and Serological Characterization of Hepatitis B Virus (HBV)-Positive Samples with Very Low or Undetectable Levels of HBV Surface Antigen.
    Kuhns MC, Holzmayer V, Anderson M, McNamara AL, Sauleda S, Mbanya D, Duong PT, Dung NTT, Cloherty GA.
    Viruses; 2021 Oct 13; 13(10):. PubMed ID: 34696483
    [Abstract] [Full Text] [Related]

  • 11. Sensitivity of individual-donation and minipool nucleic acid amplification test options in detecting window period and occult hepatitis B virus infections.
    Vermeulen M, Coleman C, Mitchel J, Reddy R, van Drimmelen H, Ficket T, Lelie N.
    Transfusion; 2013 Oct 13; 53(10 Pt 2):2459-66. PubMed ID: 23621791
    [Abstract] [Full Text] [Related]

  • 12. Hepatitis B virus DNA viral load determination in hepatitis B surface antigen-negative Swiss blood donors.
    Stolz M, Tinguely C, Fontana S, Niederhauser C.
    Transfusion; 2014 Nov 13; 54(11):2961-7. PubMed ID: 24805974
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of an individual-donation nucleic acid amplification testing algorithm for detecting hepatitis B virus infection in Chinese blood donors.
    Gou H, Pan Y, Ge H, Zheng Y, Wu Y, Zeng J, Yang Z, Pan T, Cun W, Zhou G, Fang G, Zhang J, Zhang K, Zhang R, Sun Y, Xie J, Li J, Wang L.
    Transfusion; 2015 Sep 13; 55(9):2272-81. PubMed ID: 26177670
    [Abstract] [Full Text] [Related]

  • 14. A mathematical approach to estimate the efficacy of individual-donation and minipool nucleic acid amplification test options in preventing transmission risk by window period and occult hepatitis B virus infections.
    Vermeulen M, van Drimmelen H, Coleman C, Mitchel J, Reddy R, Lelie N.
    Transfusion; 2014 Oct 13; 54(10):2496-504. PubMed ID: 24749834
    [Abstract] [Full Text] [Related]

  • 15. Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors?
    Busch MP.
    Transfus Clin Biol; 2004 Feb 13; 11(1):26-32. PubMed ID: 14980546
    [Abstract] [Full Text] [Related]

  • 16. Comprehensive analysis of hepatitis B virus infections in blood donors in southern China that are surface antigen positive but nucleic acid testing negative.
    Ye X, Li T, Zhang R, Liu H, Zeng J, Hong W, Lu L, Zhu W, Li S, Xu M, Wu S, Chen L.
    Transfusion; 2020 Jul 13; 60(7):1476-1482. PubMed ID: 32358842
    [Abstract] [Full Text] [Related]

  • 17. Detection of hepatitis B virus infection in German blood donors 2008-2015.
    Scheiblauer H, Heiden M, Funk M, Oberle D, Kreß J, Jork C, Chudy M.
    Vox Sang; 2020 Apr 13; 115(3):152-161. PubMed ID: 32023664
    [Abstract] [Full Text] [Related]

  • 18. Cost-benefit analysis of serological and nucleic acid testing for hepatitis B virus in blood donors in southern China.
    Ye X, Xiong W, Xu X, Zeng J, Xie H, Li B, He B, Chen L, Mo Q.
    BMC Infect Dis; 2024 Sep 02; 24(1):909. PubMed ID: 39223540
    [Abstract] [Full Text] [Related]

  • 19. Hepatitis B virus nucleic acid testing in Chinese blood donors with normal and elevated alanine aminotransferase.
    Ren FR, Wang JX, Huang Y, Yao FZ, Lv YL, Li JL, Wen GX, Wen XQ, Liu J, Dong XD, Ma HL, Zhou ZM, Bi XH, Tu L, King M, Nelson K, Ness P, Shan H.
    Transfusion; 2011 Dec 02; 51(12):2588-95. PubMed ID: 21682731
    [Abstract] [Full Text] [Related]

  • 20. Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy.
    Kuhns MC, Kleinman SH, McNamara AL, Rawal B, Glynn S, Busch MP, REDS Study Group.
    Transfusion; 2004 Sep 02; 44(9):1332-9. PubMed ID: 15318857
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.